Market Tracker

04/17 6:05pm ET

TG Therapeutics Inc (NASDAQ:TGTX)

5.27
Data as of Apr 17
 +0.14 / +2.73%
Today’s Change
2.97
Today|||52-Week Range
8.02
+35.13%
Year-to-Date
No recent news for TG Therapeutics Inc.

Today’s Trading

Previous close5.13
Today’s open5.15
Day’s range4.89 - 5.40
Volume112,839
Average volume (3 months)283,734
Market cap$227.7M
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)+41.30%
Earnings growth (this year)-1.54%
Earnings growth (next 5 years)--
Revenue growth (last year)+699.98%
P/E ratioNM
Price/Sales650.44
Price/Book5.26

Competitors

 Today’s
change
Today’s
% change
IGIGI Laboratories Inc-0.21-4.85%
SCLNSciClone Pharmaceuti...+0.07+1.57%
ATHXAthersys Inc+0.10+3.80%
STMLStemline Therapeutic...-0.12-0.76%
Data as of 4:00pm ET, 04/17/2014

Financials

Next reporting dateMay 12, 2014
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$152.4K
Annual profit (last year)-$20.5M
Net profit margin-13,438.82%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael S. Weiss
Chief Financial Officer, Treasurer &
Secretary
Sean A. Power
Corporate headquarters
New York, New York

Forecasts